JPS5417133A - Composition and method for limiting bile acid - Google Patents

Composition and method for limiting bile acid

Info

Publication number
JPS5417133A
JPS5417133A JP5572978A JP5572978A JPS5417133A JP S5417133 A JPS5417133 A JP S5417133A JP 5572978 A JP5572978 A JP 5572978A JP 5572978 A JP5572978 A JP 5572978A JP S5417133 A JPS5417133 A JP S5417133A
Authority
JP
Japan
Prior art keywords
limiting
composition
bile acid
bile
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5572978A
Other languages
Japanese (ja)
Inventor
Ei Kotsuku Debitsudo
Shii Gotsudofurei Jiyon
Rubinfuirudo Jiyosefu
Eru Shineidaa Donarudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of JPS5417133A publication Critical patent/JPS5417133A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP5572978A 1977-05-23 1978-05-12 Composition and method for limiting bile acid Pending JPS5417133A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79984877A 1977-05-23 1977-05-23

Publications (1)

Publication Number Publication Date
JPS5417133A true JPS5417133A (en) 1979-02-08

Family

ID=25176920

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5572978A Pending JPS5417133A (en) 1977-05-23 1978-05-12 Composition and method for limiting bile acid

Country Status (6)

Country Link
JP (1) JPS5417133A (en)
DE (1) DE2822546A1 (en)
FR (1) FR2391730A1 (en)
GB (1) GB1573487A (en)
IT (1) IT1104841B (en)
ZA (1) ZA782729B (en)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797288A (en) * 1984-10-05 1989-01-10 Warner-Lambert Company Novel drug delivery system
US4828857A (en) * 1984-10-05 1989-05-09 Warner-Lambert Company Novel sweetener delivery systems
US4804548A (en) * 1984-10-05 1989-02-14 Warner-Lambert Company Novel sweetener delivery systems
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4818539A (en) * 1985-02-05 1989-04-04 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4851392A (en) * 1985-02-05 1989-07-25 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4843098A (en) * 1985-02-05 1989-06-27 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4790991A (en) * 1985-02-05 1988-12-13 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4778676A (en) * 1985-12-20 1988-10-18 Warner-Lambert Company Confectionery delivery system for actives
US5167965A (en) * 1987-02-09 1992-12-01 The Dow Chemical Company Palatable cholestyramine granules, tablets and methods for preparation thereof
CA2129079C (en) * 1993-08-03 2006-01-17 Tatsuo Nomura Orally administrable cholesterol lowering agent
US5667775A (en) 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
WO1998012351A1 (en) * 1996-09-19 1998-03-26 Roth W Kurt Method for purifying and eventually analyzing nucleic acids from biological test samples
AU2446497A (en) * 1997-03-25 1998-10-20 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers combined with a calcium supplement for oral administration
US6726905B1 (en) 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
DE102004042139B4 (en) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Peroral dosage forms to achieve a retarding effect after drug intake with a meal
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
CA2620406A1 (en) 2005-09-02 2007-03-08 Genzyme Corporation Method for removing phosphate and polymer used therefore
EP1924246B1 (en) 2005-09-15 2015-10-21 Genzyme Corporation Sachet formulation for amine polymers
BR112013010157B1 (en) 2010-11-08 2020-02-04 Albireo Ab ibat inhibitors, their uses, and pharmaceutical composition and combinations
CN106659726A (en) 2014-06-25 2017-05-10 Ea制药株式会社 Solid preparation, and method for preventing or reducing discoloration thereof
MA41202A (en) 2014-12-18 2017-10-24 Genzyme Corp CROSS-LINKED POLYDIALLYMINE COPOLYMERS FOR THE TREATMENT OF TYPE 2 DIABETES
US10441604B2 (en) 2016-02-09 2019-10-15 Albireo Ab Cholestyramine pellets and methods for preparation thereof
US10786529B2 (en) 2016-02-09 2020-09-29 Albireo Ab Oral cholestyramine formulation and use thereof
US10441605B2 (en) 2016-02-09 2019-10-15 Albireo Ab Oral cholestyramine formulation and use thereof
JP2020530448A (en) 2017-08-09 2020-10-22 アルビレオ・アクチボラグ Cholestyramine granules, oral cholestyramine preparations, and their use
WO2019167080A1 (en) * 2018-03-01 2019-09-06 Olene Life Sciences Private Limited Bile acid sequestering composition of resin chelate and process for preparation thereof
US10793534B2 (en) 2018-06-05 2020-10-06 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
ES2942443T3 (en) 2018-06-05 2023-06-01 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
US11801226B2 (en) 2018-06-20 2023-10-31 Albireo Ab Pharmaceutical formulation of odevixibat
CN112262130A (en) 2018-06-20 2021-01-22 阿尔比里奥公司 Crystal modification of odexibart
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US10941127B2 (en) 2019-02-06 2021-03-09 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
US10975045B2 (en) 2019-02-06 2021-04-13 Aibireo AB Benzothiazepine compounds and their use as bile acid modulators
CN114786772B (en) 2019-12-04 2024-04-09 阿尔比里奥公司 Benzothiazepine compounds and their use as bile acid modulators
US11014898B1 (en) 2020-12-04 2021-05-25 Albireo Ab Benzothiazepine compounds and their use as bile acid modulators
CA3158181A1 (en) 2019-12-04 2021-06-10 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
PL4069360T3 (en) 2019-12-04 2024-04-29 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
JP2023504644A (en) 2019-12-04 2023-02-06 アルビレオ・アクチボラグ Benzothiadiazepine compounds and their use as bile acid modulators
EP4188541A1 (en) 2020-08-03 2023-06-07 Albireo AB Benzothia(di)azepine compounds and their use as bile acid modulators
AU2021379076A1 (en) 2020-11-12 2023-06-08 Albireo Ab Odevixibat for treating progressive familial intrahepatic cholestasis (pfic)
AU2021390172A1 (en) 2020-12-04 2023-06-22 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3952096A (en) * 1973-06-15 1976-04-20 Bristol-Myers Company Mixture of calcium carbonate and calcium-α-p-chlorophenoxyisobutyrate as an antihyperlipemic agent

Also Published As

Publication number Publication date
FR2391730B1 (en) 1980-07-04
GB1573487A (en) 1980-08-28
FR2391730A1 (en) 1978-12-22
IT7849461A0 (en) 1978-05-19
IT1104841B (en) 1985-10-28
DE2822546A1 (en) 1978-12-07
ZA782729B (en) 1979-06-27

Similar Documents

Publication Publication Date Title
JPS5417133A (en) Composition and method for limiting bile acid
JPS5452722A (en) Pharmaceutical composition based on copolyoxalic acid ester and method
JPS5464695A (en) Substance composition and method
JPS5416453A (en) Composition and method
JPS54160403A (en) Washhbleaching composition and method
IL58017A0 (en) Method and composition for treating cardiovascular diseases
JPS5387346A (en) Labelled bile acid
JPS549265A (en) Composition and method
BG36637A3 (en) Elastoplastic composition and method for its manufacture
GB2000030A (en) Bacteriostatic composition and method
JPS53139730A (en) Pharmaceutical composition and method
BG31484A3 (en) Copyng composition and method for its obtaining
JPS5492953A (en) Composition and method
JPS53127383A (en) Scale controlling composition and controlling method
CS222255B2 (en) Method of increasing the portion of the deisred anantiometer in the acid component of the 2-arylpropion acid
ZA78969B (en) Solid steroid composition and process for preparation
JPS54149700A (en) Method of analyzing bile acid
JPS53103497A (en) Heterocyclopyrimidines composition and treating method
JPS53120754A (en) Fillerrcontaining composition and method of making same
JPS5463031A (en) Propanethio acid derivative and its composition
AU3972178A (en) Prostaglandin composition and method
DE2860609D1 (en) Bis-azido-phthalic acid derivatives and process for their preparation
GR62435B (en) Compositions and method for decreasing substrates
JPS53141259A (en) Process for preparing steroidal acid and intermediate thereof
JPS5492952A (en) Composition and method